The primary objective of this study is to demonstrate the impacts of Ki-67 and PCT expression levels in cancer tissue on post-transplant recurrence and survival, utilizing clinical and oncological data, in order to determine the potential of Ki-67 and PCT as biomarkers. The gene discussed is MKI67; the disease is cancer.